Craig Langman - Grants - Northwestern Scholars

View Scopus Profile

Phone+1 312 227 6555
Emailc-langmannorthwesternedu

h-index
h10-index
h5-index

Research activity per year

7 Active
22 Finished

7 results

Filter

Active
The Northwestern Summer Research Program for Medical Students
Ladner, D. P. (PD/PI), Ladner, D. P. (PD/PI), Feinstein, M. J. (Other), Feinstein, M. J. (Other) & Langman, C. (Other)
National Institute of Diabetes and Digestive and Kidney Diseases
9/1/21 → 8/31/26
Project: Research project
Achillion 205: An Open-Label Phase 2 Proof-of-Concept Study in Patients with C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Treated with ACH-0144471
Langman, C. (PD/PI)
Achillion Pharmaceuticals, Inc.
5/16/19 → 8/31/50
Project: Research project
North American Pediatric Renal Transplant Cooperative Study--Cystinosis Registry
Langman, C. (PD/PI)
North American Pediatrics Renal Transplant Case Study
11/14/18 → 8/31/50
Project: Research project
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG012-03 for Injection Administered Every 2 Weeks in Patients with Alport Syndrome
Langman, C. (PD/PI)
Regulus Therapeutics Inc.
6/4/18 → 8/31/50
Project: Research project
RG012-06: A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of Subcutaneous RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects with Alport Syndrome
Langman, C. (PD/PI)
Regulus Therapeutics Inc.
6/4/18 → 8/31/50
Project: Research project
UX023-CL401-X-linked Hypophosphatemia Disease Monitoring Program - XLH-DMP
Langman, C. (PD/PI)
Ultragenyx Pharmaceutical Inc.
4/30/18 → 8/31/50
Project: Research project
ECU-aHUS-403: Evaluation of Potential Predictors of Disease Progression in Patients with aHUS, Including Genetics, Biomarkers, and Treatment
Langman, C. (PD/PI)
Alexion Pharmaceuticals, Inc
1/1/17 → 8/31/50
Project: Research project